TY - JOUR
T1 - Iatrogenic splenectomy during nephrectomy for renal tumors
AU - Wang, Jeffrey K.
AU - Tollefson, Matthew K.
AU - Kim, Simon P.
AU - Boorjian, Stephen A.
AU - Leibovich, Bradley C.
AU - Lohse, Christine M.
AU - Cheville, John C.
AU - Thompson, R. Houston
PY - 2013/9
Y1 - 2013/9
N2 - Objectives: To evaluate risk factors associated with iatrogenic splenectomy during nephrectomy and to assess outcomes among patients undergoing nephrectomy for renal tumors. Methods: Of 4323 patients who underwent nephrectomy at Mayo Clinic between 1992 and 2008, 33 (0.8%) had an iatrogenic/unplanned splenectomy. In a case-control study design, controls without splenectomy were matched 1:3 based on age, sex, surgical date, side of the renal tumor, surgical approach and surgeon. Perioperative features and survival were evaluated using conditional logistic and Cox regression. Results: Among the 33 iatrogenic splenectomy patients, the majority (94%) underwent radical, open and left-sided nephrectomy. Primary tumor classification ≥T3 was the only clinicopathological risk factor significantly associated with splenectomy (odds ratio 3.4; P=0.02). Compared with controls, patients with an iatrogenic splenectomy were more likely to have longer operative time (205 vs 171min; P=0.02), higher estimated blood loss (1.3 vs 0.3L; P=0.001), longer length of stay (median 7 vs 5 days; P=0.03) and a higher likelihood for postoperative complications (odds ratio 5.3; P=0.002). With a median of 9.8years of follow up, splenectomy patients tended to have greater all-cause mortality (hazard ratio 1.6; P=0.07), although this difference approached statistical significance. Conclusions: Iatrogenic splenectomy is a rare complication during nephrectomy and is associated with locally advanced tumors (≥pT3). It also carries prognostic significance for adverse perioperative outcomes and possibly diminished survival, although this warrants further study.
AB - Objectives: To evaluate risk factors associated with iatrogenic splenectomy during nephrectomy and to assess outcomes among patients undergoing nephrectomy for renal tumors. Methods: Of 4323 patients who underwent nephrectomy at Mayo Clinic between 1992 and 2008, 33 (0.8%) had an iatrogenic/unplanned splenectomy. In a case-control study design, controls without splenectomy were matched 1:3 based on age, sex, surgical date, side of the renal tumor, surgical approach and surgeon. Perioperative features and survival were evaluated using conditional logistic and Cox regression. Results: Among the 33 iatrogenic splenectomy patients, the majority (94%) underwent radical, open and left-sided nephrectomy. Primary tumor classification ≥T3 was the only clinicopathological risk factor significantly associated with splenectomy (odds ratio 3.4; P=0.02). Compared with controls, patients with an iatrogenic splenectomy were more likely to have longer operative time (205 vs 171min; P=0.02), higher estimated blood loss (1.3 vs 0.3L; P=0.001), longer length of stay (median 7 vs 5 days; P=0.03) and a higher likelihood for postoperative complications (odds ratio 5.3; P=0.002). With a median of 9.8years of follow up, splenectomy patients tended to have greater all-cause mortality (hazard ratio 1.6; P=0.07), although this difference approached statistical significance. Conclusions: Iatrogenic splenectomy is a rare complication during nephrectomy and is associated with locally advanced tumors (≥pT3). It also carries prognostic significance for adverse perioperative outcomes and possibly diminished survival, although this warrants further study.
KW - Iatrogenic splenectomy
KW - Incidental splenectomy
KW - Nephrectomy complications
UR - http://www.scopus.com/inward/record.url?scp=84883453798&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883453798&partnerID=8YFLogxK
U2 - 10.1111/iju.12065
DO - 10.1111/iju.12065
M3 - Article
C2 - 23379901
AN - SCOPUS:84883453798
VL - 20
SP - 896
EP - 902
JO - International Journal of Urology
JF - International Journal of Urology
SN - 0919-8172
IS - 9
ER -